Refractory mogamulizumab-associated rash responding to an oral Janus kinase inhibitor

• Carine M. Lama, MS,
• Miguel A. Hernandez-Rovira, BSc,
• Neha Mehta-Shah, MD,
• Aaron Russell, MD,
• Amy C.M. Musiek, MD

Affiliations

Carine M. Lama, MS

Washington University School of Medicine, St. Louis, Missouri; Correspondence to: Carine M. Lama, MS, Washington University School of Medicine, 660 S. Euclid Ave, St. Louis, MO 63110.

Miguel A. Hernandez-Rovira, BSc

Washington University School of Medicine, St. Louis, Missouri; Miguel A. Hernandez-Rovira, BSc, Washington University School of Medicine, 660 S. Euclid Ave, St. Louis, MO 63110.

Neha Mehta-Shah, MD

Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri

Aaron Russell, MD

Division of Dermatology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri

Amy C.M. Musiek, MD

Division of Dermatology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri